Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of $207.64 billion. The enterprise value is $228.19 billion.
| Market Cap | 207.64B |
| Enterprise Value | 228.19B |
Important Dates
The last earnings date was Thursday, July 18, 2024, before market open.
| Earnings Date | Jul 18, 2024 |
| Ex-Dividend Date | Mar 7, 2024 |
Share Statistics
Novartis AG has 1.96 billion shares outstanding.
| Shares Outstanding | 1.96B |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 6.94% |
| Float | 1.93B |
Valuation Ratios
The trailing PE ratio is 21.70 and the forward PE ratio is 13.25. Novartis AG's PEG ratio is 5.09.
| PE Ratio | 21.70 |
| Forward PE | 13.25 |
| PS Ratio | 4.25 |
| Forward PS | 4.08 |
| PB Ratio | 4.98 |
| P/FCF Ratio | 14.53 |
| PEG Ratio | 5.09 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.37, with an EV/FCF ratio of 15.97.
| EV / Earnings | 14.11 |
| EV / Sales | 4.67 |
| EV / EBITDA | 8.37 |
| EV / EBIT | 12.75 |
| EV / FCF | 15.97 |
Financial Position
The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.69.
| Current Ratio | 0.93 |
| Quick Ratio | 0.60 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 1.06 |
| Debt / FCF | 2.03 |
| Interest Coverage | 19.75 |
Financial Efficiency
Return on equity (ROE) is 38.90% and return on invested capital (ROIC) is 15.79%.
| Return on Equity (ROE) | 38.90% |
| Return on Assets (ROA) | 16.00% |
| Return on Capital (ROIC) | 15.79% |
| Revenue Per Employee | $642,413 |
| Profits Per Employee | $212,669 |
| Employee Count | 76,057 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 1.78 |
Taxes
In the past 12 months, Novartis AG has paid $814.00 million in taxes.
| Income Tax | 814.00M |
| Effective Tax Rate | 4.79% |
Stock Price Statistics
The stock price has increased by +2.82% in the last 52 weeks. The beta is 0.49, so Novartis AG's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +2.82% |
| 50-Day Moving Average | 105.15 |
| 200-Day Moving Average | 100.40 |
| Relative Strength Index (RSI) | 45.31 |
| Average Volume (20 Days) | 1,482,242 |
Short Selling Information
| Short Interest | 6.28M |
| Short Previous Month | 3.92M |
| Short % of Shares Out | 0.26% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.58 |
Income Statement
In the last 12 months, Novartis AG had revenue of $48.86 billion and earned $16.18 billion in profits. Earnings per share was $7.86.
| Revenue | 48.86B |
| Gross Profit | 36.45B |
| Operating Income | 11.73B |
| Pretax Income | 16.99B |
| Net Income | 16.18B |
| EBITDA | 27.27B |
| EBIT | 17.90B |
| Earnings Per Share (EPS) | $7.86 |
Balance Sheet
The company has $8.44 billion in cash and $28.99 billion in debt, giving a net cash position of -$20.55 billion or -$10.50 per share.
| Cash & Cash Equivalents | 8.44B |
| Total Debt | 28.99B |
| Net Cash | -20.55B |
| Net Cash Per Share | -$10.50 |
| Equity (Book Value) | 41.73B |
| Book Value Per Share | 21.33 |
| Working Capital | -1.92B |
Cash Flow
In the last 12 months, operating cash flow was $15.07 billion and capital expenditures -$773.00 million, giving a free cash flow of $14.29 billion.
| Operating Cash Flow | 15.07B |
| Capital Expenditures | -773.00M |
| Free Cash Flow | 14.29B |
| FCF Per Share | $7.03 |
Margins
Gross margin is 74.60%, with operating and profit margins of 24.01% and 33.10%.
| Gross Margin | 74.60% |
| Operating Margin | 24.01% |
| Pretax Margin | 34.77% |
| Profit Margin | 33.10% |
| EBITDA Margin | 55.81% |
| EBIT Margin | 36.63% |
| FCF Margin | 29.25% |
Dividends & Yields
This stock pays an annual dividend of $3.78, which amounts to a dividend yield of 3.56%.
| Dividend Per Share | $3.78 |
| Dividend Yield | 3.56% |
| Dividend Growth (YoY) | 8.88% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 48.05% |
| Buyback Yield | 2.34% |
| Shareholder Yield | 5.90% |
| Earnings Yield | 7.79% |
| FCF Yield | 6.88% |
Analyst Forecast
The average price target for Novartis AG is $117.50, which is 10.71% higher than the current price. The consensus rating is "Buy".
| Price Target | $117.50 |
| Price Target Difference | 10.71% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 3.12% |
| EPS Growth Forecast (5Y) | 5.71% |
Stock Splits
The last stock split was on April 9, 2019. It was a forward split with a ratio of 1116:1000.
| Last Split Date | Apr 9, 2019 |
| Split Type | Forward |
| Split Ratio | 1116:1000 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |